Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 2/20 | 1.00 |
| ▸ | CSNK2B | P67870 | 2/20 | 1.00 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 1.00 |
| ▸ | CSNK2A3 | Q8NEV1 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.73 |
| ▸ | HPGD | P15428 | 4/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.73 |
| ▸ | POLB | P06746 | 3/20 | 0.73 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.73 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.73 |
| ▸ | CSNK1G1 | Q9HCP0 | 2/20 | 0.73 |
| ▸ | BLM | P54132 | 2/20 | 0.73 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.73 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.73 |
| ▸ | PLEC | Q15149 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 4/20 | 0.70 |
| ▸ | NQO1 | P15559 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29031600 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL31158152 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL498572 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL504063 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL11146282 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL3843709 | 1.00 | CSNK2A2 (1.00) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| Bromide SCHEMBL6352560 | 0.98 | CSNK2A2 (0.95) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| Hydrochloric Acid SCHEMBL4191951 | 0.98 | CSNK2A2 (0.95) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL10356109 | 0.88 | CSNK2A2 (0.77) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 | |
| SCHEMBL9619618 | 0.88 | CSNK2A2 (0.77) | CSNK2A2CSNK2BCSNK2A1CSNK2A3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703794-A1 | FLEXOGRAPHIC PRINTING ORIGINAL PLATE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE | Asahi Kasei Kabushiki Kaisha (JP) | 2026-03-04 | — | — | EP | claimed |
| WO-2024225145-A1 | FLEXOGRAPHIC PRINTING ORIGINAL PLATE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE | 旭化成株式会社 | 2024-10-31 | — | — | WO | claimed |
| US-5548039-A | CONDENSATION PRODUCT OF ANTHRAQUINONE COMPOUND HAVING AT LEAST TWO AMINO GROUPS AND EITHER BENZOQUINONE AND OR NAPHTHOQUINONE COMPOUNDS | SHIN-ETSU CHEMICAL CO., LTD (JP) | 1996-08-20 | — | — | US | claimed |
| EP-4703794-A1 | FLEXOGRAPHIC PRINTING ORIGINAL PLATE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE | Asahi Kasei Kabushiki Kaisha (JP) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024225145-A1 | FLEXOGRAPHIC PRINTING ORIGINAL PLATE, AND METHOD FOR MANUFACTURING FLEXOGRAPHIC PRINTING PLATE | 旭化成株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-20240034799-A1 | METHODS AND SYSTEMS OF STRATIFYING INFLAMMATORY DISEASE PATIENTS | CEDARS SINAI MEDICAL CENTER (US) | 2024-02-01 | — | — | US | disclosed |
| EP-4256086-A1 | METHODS AND SYSTEMS OF STRATIFYING INFLAMMATORY DISEASE PATIENTS | Cedars-Sinai Medical Center (US) | 2023-10-11 | — | — | EP | disclosed |
| US-20230279491-A1 | TREATMENTS FOR A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | CEDARS-SINAI MEDICAL CENTER | 2023-09-07 | — | — | US | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-20050041093-A1 | Media construction for use in auto-focus laser | KODAK POLYCHROME GRAPHICS LLC | 2005-02-24 | — | — | US | disclosed |
| US-5548039-A | CONDENSATION PRODUCT OF ANTHRAQUINONE COMPOUND HAVING AT LEAST TWO AMINO GROUPS AND EITHER BENZOQUINONE AND OR NAPHTHOQUINONE COMPOUNDS | SHIN-ETSU CHEMICAL CO., LTD (JP) | 1996-08-20 | — | — | US | disclosed |
| US-3975285-A | LONG LIFE DYNAMIC LIGHT SCATTERING PROPERTIES | HODOGAYA CHEMICAL CO., LTD. (JA) | 1976-08-17 | — | — | US | disclosed |
| US-3956345-A | POLYESTER | CIBA-GEIGY AG (CH) | 1976-05-11 | — | — | US | disclosed |
| US-3939113-A | ANTHRAQUINONE DYES | CIBA-GEIGY CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
| US-3865851-A | Manufacture of anthraquinone compounds | ICI LTD | 1975-02-11 | — | — | US | disclosed |